• ACSL1-FSP1 Axis Drives Ferroptosis Resistance in Ovarian Can

  2026-05-15

  The referenced study elucidates how ACSL1 enhances platinum resistance in ovarian cancer by promoting FSP1 N-myristoylation and stability, thereby suppressing ferroptosis. These mechanistic insights have implications for targeting lipid metabolism and ferroptosis pathways in cancer therapy and resistance management.

• Formononetin Mitigates Oxaliplatin Neurotoxicity via Nrf2/HO

  2026-05-14

  This study identifies formononetin as a neuroprotective agent that shields sensory neurons from oxaliplatin-induced oxidative stress and apoptosis by activating the Nrf2/HO-1 pathway, while crucially preserving the chemotherapy’s anticancer efficacy. The findings highlight a promising strategy to address the unmet need for preventing chemotherapy-induced peripheral neuropathy (CIPN) without compromising cancer treatment outcomes.

• Neuromedin S (rat): Technical Guidance for GPCR Assays

  2026-05-14

  Neuromedin S (rat) is a chemically defined peptide agonist enabling precise activation of neuromedin U receptor signaling in rat GPCR/G protein research. This product is intended for controlled laboratory workflows, not for diagnostic or therapeutic applications. Researchers must adhere to recommended solubility and storage protocols for reproducible results.

• HyperFluor 488 Goat Anti-Mouse IgG: Precision in Vascular As

  2026-05-13

  The HyperFluor™ 488 Goat Anti-Mouse IgG (H+L) Antibody offers unmatched sensitivity and reproducibility in immunofluorescence and flow cytometry, crucial for quantifying vascular injury and repair. Its advanced dye conjugation and robust affinity purification empower researchers to streamline workflows and achieve high-fidelity detection of mouse IgG targets in complex experimental models.

• Methyl-β-cyclodextrin: Workflow Guide for Membrane Studies

  2026-05-13

  Methyl-β-cyclodextrin (SKU C6939) is a high-purity reagent designed for selective extraction of membrane cholesterol and other lipids, enabling controlled studies of membrane fluidity, lipid raft disruption, and cholesterol-dependent signaling pathways. It is intended strictly for laboratory research, not for diagnostic or medical use, and requires careful attention to solubility, storage, and workflow parameters to maintain efficacy.

• HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody: Technic

  2026-05-12

  The HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody addresses the need for sensitive, specific fluorescent detection of rabbit primary antibodies in immunofluorescence, immunohistochemistry, and related assays. It is unsuitable for direct detection of non-rabbit targets or for chromogenic workflows requiring enzymatic reporters.

• Cy3 Goat Anti-Rabbit IgG (H+L) Antibody: Reliable Signal in

  2026-05-12

  This article explores laboratory scenarios where the Cy3 Goat Anti-Rabbit IgG (H+L) Antibody (SKU K1209) addresses challenges in immunofluorescence, IHC, and ICC assays. Grounded in peer-reviewed evidence and best practices, it guides biomedical researchers on optimizing sensitivity, reproducibility, and workflow efficiency with this Cy3-conjugated secondary antibody.

• HotStart Universal 2X Green qPCR Master Mix: Precision in Ge

  2026-05-11

  The HotStart™ Universal 2X Green qPCR Master Mix streamlines real-time PCR gene expression analysis with robust specificity, universal compatibility, and simplified melt curve validation. Its integrated hot-start Taq polymerase and ROX reference dye enable reproducible results, making it a trusted choice for complex experiments like neurogenetic rescue studies.

• ICG001: Wnt/β-Catenin Pathway Inhibitor for Fibrosis Models

  2026-05-11

  ICG001 enables precise dissection of CBP/β-catenin signaling in fibrosis and cancer research, offering researchers a robust tool for targeted pathway modulation. This article delivers actionable workflows, protocol enhancements, and troubleshooting insights, contextualized by recent advances in EMT-driven liver fibrosis.

• Red Blood Cell Lysis Buffer: Enabling Purity in Osteogenic A

  2026-05-10

  Explore how Red Blood Cell Lysis Buffer ensures selective erythrocyte removal for advanced osteogenic and immunological workflows. Discover unique protocol insights, comparative analysis, and evidence-driven guidance for optimal blood sample preparation.

• HBsAg Manipulates TBK1 to Suppress Interferon and Trigger Au

  2026-05-09

  This study uncovers a mechanism by which hepatitis B surface antigen (HBsAg) hijacks TANK-binding kinase 1 (TBK1), suppressing type I interferon signaling and inducing early autophagy. These findings offer new insight into HBV immune evasion and highlight potential molecular targets for antiviral intervention.

• RNA Pol II Inhibition Triggers Apoptosis via Signaling, Not

  2026-05-08

  Harper et al. (2025) reveal that cell death following RNA Pol II inhibition is not a passive consequence of mRNA depletion but an actively signaled apoptotic process initiated by the loss of hypophosphorylated RNA Pol IIA. This discovery reframes our understanding of transcriptional inhibition lethality and provides a new framework for dissecting regulated cell death mechanisms.

• Comparative Radiosensitization: 2D vs 3D Models in DNA Damag

  2026-05-08

  This study systematically evaluates molecular targeted radiosensitizers in both 2D and 3D lung cancer cell culture models. The findings highlight that ATR and DNA-PKcs inhibitors provide consistent and robust radiosensitization, with 3D models revealing additional context-specific effects relevant for preclinical prioritization and translational research.

• Dextromethorphan Hydrobromide: Advanced NMDA Antagonist Work

  2026-05-07

  Dextromethorphan hydrobromide from APExBIO offers unmatched reproducibility and specificity in neuroprotection and excitotoxicity research. This guide details experimental workflows, troubleshooting tactics, and protocol enhancements for leveraging its NMDA receptor antagonist properties in both in vitro and in vivo neuroscience studies.

• EZ Cap™ Firefly Luciferase mRNA: Precision for mRNA Delivery

  2026-05-07

  EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure sets a new benchmark for sensitive, quantitative mRNA delivery and translation efficiency assays. Its advanced capping and poly(A) tail design ensure robust bioluminescent readouts, empowering both in vitro and in vivo applications with minimal troubleshooting and maximal translational impact.

10179 records 1/679 page Next 12345 下5页 Last page